2m 2m 2m 2m 2m 2m 2m
ENVERIC BIOSCIE (ENVB)
NASDAQ
$2.00+$0.02 (+1.01%)
Price as of Jun 03, 2026 7:40 PM EDT- $8.5MMarket Cap
- -85.43%1-Year Change
- BiotechnologyIndustry
ENVERIC BIOSCIE (ENVB)
$2.00+$0.02 (+1.01%)
ENVB | vs History | vs S&P 500 | |
|---|---|---|---|
General Statistics | |||
Latest Close | $1.98 | ||
Change | -$0.04 (-1.77%) | ||
Open | $2.22 | ||
High | $2.25 | ||
Low | $1.96 | ||
Previous Close | $2.22 | ||
Volume | 120,864 | ||
30-Day Average Volume | 280,673 | ||
1-Week Change | -0.45% | ||
1-Month Change | -44.36% | ||
1-Year Change | -85.43% | ||
3-Year Change | -99.69% | ||
5-Year Change | -99.99% | ||
Fundamentals | |||
Shares Outstanding | 3.7M | ||
Total Assets | $5.5M | ||
Market Cap | $8.5M | ||
Enterprise Value | $3.6M | ||
Period: QTR TTM FY | |||
Revenue | -$303.00 | ||
Net Income | -$1.6M | ||
Free Cash Flow | -$2.3M | ||
EBIT | -$1.6M | ||
EBITDA | -$1.6M | ||
Net Working Capital | $4.9M | ||
EPS | -$1.08 | ||
Enterprise Value/EBITDA | -2 | ||
Enterprise Value/Revenue | -11,748 | ||
P/B | 2 | ||
P/E | -2 | ||
PEG | 0 | ||
Price/Free Cash Flow | -4 | ||
Price/Operating Cash Flow | -4 | ||
Dividends & Splits | |||
Forward Annual Dividend Yield | N/A | ||
Trailing Annual Dividend Yield | N/A | ||
Ex-Dividend Date | N/A | ||
Last Split Factor | 1 : 12 | ||
Last Split Date | 10/28/2025 | ||
Earnings & Revenue